Kdquine Tablet

About Kdquine 250 mg Tablet

Kdquine 250 mg Tablet contains Chloroquine Phosphate, an anti-malarial medicine. It is used to treat and prevent malaria and certain other conditions as prescribed by a doctor.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Kdquine 250 mg Tablet?

Kdquine 250 mg Tablet is a medicine with Chloroquine Phosphate as its active ingredient. It belongs to a group of drugs known as anti-malarials. Doctors prescribe it for treating malaria and for preventing malaria in people who are at risk. It is also used in the treatment of amoebic hepatitis and amoebic abscess, and for some inflammatory conditions such as discoid and systemic lupus erythematosus and rheumatoid arthritis. The medicine works against the malaria parasite in the blood. Always use it under medical supervision, as the doctor will decide the right course for your condition.

Uses of Kdquine

Kdquine 250 mg Tablet is used to treat malaria and to prevent or suppress malaria. It is also prescribed for amoebic hepatitis and amoebic abscess. In addition, doctors may use it for discoid and systemic lupus erythematosus and for rheumatoid arthritis. Your doctor will determine if this medicine is suitable for your specific health condition.

How to use Kdquine

Take Kdquine 250 mg Tablet exactly as your doctor tells you. The dose and how long you take it will depend on your condition and will be decided by your doctor. Swallow the tablet with water, and try to take it at the same time each day if your doctor advises. Do not change the dose or stop the medicine without consulting your doctor. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Kdquine

Most people tolerate Kdquine 250 mg Tablet well at the prescribed dose. Some may experience headache or stomach upset, which are usually not serious. With prolonged use at high doses, more serious side effects can occur, such as skin rashes, hair loss, difficulty focusing the eyes, or blurred vision. Rarely, blood disorders like low platelets or anaemia have been reported. Long-term use may rarely cause eye damage. Tell your doctor if you notice any unusual symptoms.

Safety and precautions

Before taking Kdquine 250 mg Tablet, tell your doctor if you have liver problems, porphyria, or any other health conditions. The use of this medicine during pregnancy should be avoided if possible, unless your doctor decides the benefit outweighs the risk. If you are breastfeeding, ask your doctor for advice. People with a history of eye problems or blood disorders should inform their doctor. Your doctor may recommend eye examinations if you take this medicine for a long time. Always follow your doctor's instructions and do not self-medicate.

Frequently asked questions

What is the generic name of Kdquine and what does it mean?

The generic name is Chloroquine Phosphate. It is a chemical name for the active ingredient that belongs to a class of medicines called anti-malarials. Your doctor or pharmacist can explain more about how it works.

What is Kdquine 250 mg Tablet used for and what kind of medicine is it?

It is an anti-malarial medicine used to treat and prevent malaria. It is also used for amoebic hepatitis and amoebic abscess, and for some inflammatory conditions like lupus and rheumatoid arthritis. Your doctor will decide if it is right for you.

How should I take Kdquine 250 mg Tablet?

Take it exactly as your doctor prescribes. The dose and duration depend on your condition and will be decided by your doctor. Swallow the tablet with water and do not change the dose without medical advice.

Can I take Kdquine 250 mg Tablet during pregnancy?

The use of this medicine during pregnancy should be avoided if possible, unless your doctor judges that the benefit outweighs the risk. Always consult your doctor before taking any medicine during pregnancy or while breastfeeding.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.